Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands |
Total |
Common Stock |
Treasury Stock |
Additional Paid-In Capital |
Retained Earnings |
| Stockholders' equity at beginning of period at Dec. 31, 2018 |
$ 389,932
|
$ 3
|
$ (79,571)
|
$ 348,397
|
$ 121,102
|
| Shares at beginning of period (in shares) at Dec. 31, 2018 |
|
31,345,220
|
(3,947,460)
|
|
|
| Increase in stockholders' equity: |
|
|
|
|
|
| Share compensation expense |
2,806
|
|
|
2,806
|
|
| Exercise of stock options |
37
|
$ 0
|
|
37
|
|
| Exercise of stock options (in shares) |
|
3,000
|
|
|
|
| Common stock issued for vested restricted stock |
0
|
$ 0
|
|
0
|
|
| Common stock issued for vested restricted stock (in shares) |
|
215,071
|
|
|
|
| Common stock issued for vested performance shares |
0
|
$ 0
|
|
0
|
|
| Common stock issued for vested performance shares (in shares) |
|
13,267
|
|
|
|
| Common shares withheld and retired to satisfy employee tax withholding obligations upon vesting of restricted stock |
(1,978)
|
$ 0
|
|
(1,978)
|
|
| Common shares withheld and retired to satisfy employee tax withholding obligations upon vesting of restricted stock (in shares) |
|
(81,936)
|
|
|
|
| Repurchase of convertible notes, net of deferred taxes |
36
|
|
|
36
|
|
| Purchases of treasury stock |
(10,629)
|
|
$ (10,629)
|
|
|
| Purchase of treasury stock (in shares) |
|
|
(452,350)
|
|
|
| Net loss |
3,497
|
|
|
|
3,497
|
| Stockholders' equity at end of period at Mar. 31, 2019 |
383,700
|
$ 3
|
$ (90,199)
|
349,298
|
124,599
|
| Shares at end of period (in shares) at Mar. 31, 2019 |
|
31,494,622
|
(4,399,810)
|
|
|
| Stockholders' equity at beginning of period at Dec. 31, 2019 |
383,312
|
$ 3
|
$ (109,239)
|
356,600
|
135,948
|
| Shares at beginning of period (in shares) at Dec. 31, 2019 |
|
31,507,247
|
(5,277,438)
|
|
|
| Increase in stockholders' equity: |
|
|
|
|
|
| Share compensation expense |
4,608
|
|
|
4,608
|
|
| Exercise of stock options |
381
|
$ 0
|
|
381
|
|
| Exercise of stock options (in shares) |
|
32,000
|
|
|
|
| Common stock issued for vested restricted stock |
0
|
$ 0
|
|
0
|
|
| Common stock issued for vested restricted stock (in shares) |
|
247,224
|
|
|
|
| Common shares withheld and retired to satisfy employee tax withholding obligations upon vesting of restricted stock |
(1,541)
|
$ 0
|
|
(1,541)
|
|
| Common shares withheld and retired to satisfy employee tax withholding obligations upon vesting of restricted stock (in shares) |
|
(82,802)
|
|
|
|
| Repurchase of convertible notes, net of deferred taxes |
(190)
|
|
|
(190)
|
|
| Purchases of treasury stock |
(9,440)
|
|
$ (9,440)
|
|
|
| Purchase of treasury stock (in shares) |
|
|
(489,662)
|
|
|
| Net loss |
(2,933)
|
|
|
|
(2,933)
|
| Stockholders' equity at end of period at Mar. 31, 2020 |
$ 374,197
|
$ 3
|
$ (118,679)
|
$ 359,857
|
$ 133,015
|
| Shares at end of period (in shares) at Mar. 31, 2020 |
|
31,703,669
|
(5,767,100)
|
|
|